Gene Information
Gene Name
|
MTOR |
Gene ID
|
2475
|
Gene Full Name
|
mechanistic target of rapamycin kinase |
Gene Alias
|
SKS; FRAP; FRAP1; FRAP2; RAFT1; RAPT1 |
Transcripts
|
ENSG00000198793
|
Virus
|
HBV |
Gene Type
|
protein coding |
HPA Location Info
|
Cytosol;Vesicles;
|
HPA Protein Class Info
|
Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins |
Gene Function
|
Oncogene
|
Uniport_ID
|
P42345
|
HGNC ID
|
HGNC:3942
|
VEGA ID
|
OTTHUMG00000002001
|
OMIM ID
|
601231 |
String ID
|
9606.ENSP00000354558
|
Drugbank ID
|
BE0002386
|
Drug (Cytoscape Annotation)
|
Everolimus |
PharmGKB ID
|
PA28360
|
FDA Approved Drug
|
Everolimus;Temsirolimus |
Target gene [MTOR] related to VISs
DVID |
Chromosome |
HM |
TFBS |
CA |
Sum of Overlapped Records |
Detail |
1008510 |
chr1 |
13 |
5 |
2 |
20 |
View |
Relationship between gene expression and immune infiltrating cell level
Data ID |
Disease |
Sample number |
Sample type |
LIHC (TCGA) |
Liver hepatocellular carcinoma |
424 |
Liver hepatocellular carcinoma HCV (HBV+)(86), Liver hepatocellular carcinoma HCV (HBV-)(19), Liver hepatocellular carcinoma (HBV+)(209), Liver hepatocellular carcinoma (HBV+)(60), Paracancerous HCV (HBV+)(4), Paracancerous (HBV-)(28), Paracancerous (HBV+)(18) |
> Dataset: LIHC
|
HeatMap of cell type fractions in all samples
|
Lollipop of MTOR expression and immune infiltrating cell level correlation result in HBV+ samples
|
MTOR expression: Low -> High
|
|
|
|
|